Polymyxin B

Antibiotic

Phase of research

FDA-/EMA-approved for Other Purpose

How it helps

Anti-Infective

General information

N/A

Synonyms

N/A

Marketed as

N/A

Dietary sources

N/A

Structure image not available

C56H98N16O13

Drug-Mutation Relation

Treats

Mutation Number of sources Average impact factor
General effect
1 6.27
Link Tested on Impact factor Notes
An ‘unlikely’ pair: The antimicrobial synergy of polymyxin B in combination with the cystic fibrosis trans-membrane conductance regulator drugs KALYDECO and ORKAMBI bacterial cell culture 6.27 Effective in combination with ivacaftor or ivacaftor-lumacaftor.

Does not treat

Mutation Number of sources Average impact factor